- Home
- NVRI vs ORIC Comparison
NVRI vs ORIC Comparison
Compare NVRI & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRI
- ORIC
- Stock Information
- Founded
- NVRI 1853
- ORIC 2014
- Country
- NVRI United States
- ORIC United States
- Employees
- NVRI N/A
- ORIC N/A
- Industry
- NVRI Diversified Commercial Services
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- NVRI Miscellaneous
- ORIC Health Care
- Exchange
- NVRI Nasdaq
- ORIC Nasdaq
- Market Cap
- NVRI 996.0M
- ORIC 1.1B
- IPO Year
- NVRI N/A
- ORIC 2020
- Fundamental
- Price
- NVRI $12.21
- ORIC $13.16
- Analyst Decision
- NVRI Hold
- ORIC Strong Buy
- Analyst Count
- NVRI 1
- ORIC 8
- Target Price
- NVRI $10.00
- ORIC $16.57
- AVG Volume (30 Days)
- NVRI 728.1K
- ORIC 1.5M
- Earning Date
- NVRI 11-10-2025
- ORIC 11-06-2025
- Dividend Yield
- NVRI N/A
- ORIC N/A
- EPS Growth
- NVRI N/A
- ORIC N/A
- EPS
- NVRI N/A
- ORIC N/A
- Revenue
- NVRI $2,242,873,000.00
- ORIC N/A
- Revenue This Year
- NVRI N/A
- ORIC N/A
- Revenue Next Year
- NVRI $3.72
- ORIC N/A
- P/E Ratio
- NVRI N/A
- ORIC N/A
- Revenue Growth
- NVRI N/A
- ORIC N/A
- 52 Week Low
- NVRI $4.72
- ORIC $3.90
- 52 Week High
- NVRI $13.53
- ORIC $14.93
- Technical
- Relative Strength Index (RSI)
- NVRI 47.98
- ORIC 54.79
- Support Level
- NVRI $12.54
- ORIC $12.75
- Resistance Level
- NVRI $13.53
- ORIC $13.80
- Average True Range (ATR)
- NVRI 0.49
- ORIC 0.72
- MACD
- NVRI -0.09
- ORIC -0.08
- Stochastic Oscillator
- NVRI 30.16
- ORIC 58.97
About NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.